INDUSTRY UPDATE: Notes from the invitation-only JP Morgan Healthcare virtual conference
During the week of January 11, 2021, JP Morgan conducted their annual healthcare conference. Having attended for several years we wanted to provide a few relevant highlights for our investors.
As a consequence of the COVID-19 pandemic there has been an increased acceptance in the use of point of care testing to determine who has COVID-19 antibodies and who has an active viral infection. This is great news for our company. Now that the public and healthcare professionals have familiarity with portable digitized testing outside the hospital, the path for utilizing point of care diagnostics like SimpleTestTM for drugs of abuse and a range of medical conditions is paved.
At the meeting, CVS’ leadership team expressed their common purpose “of helping people on their path to better health. In an increasingly connected and digital world, we are meeting people wherever they are and changing health care to meet their needs.” Being connected to multiple healthcare data cloud portals allows SimpleTestTM to fit squarely into CVS’ “connected and digital world.”
Rite Aid’s Leadership team led by Heyward Donigan, President and CEO, has launched what they call an Rxevolution that emphasizes the Pharmacist, and will be training Pharmacists to also act as a technician to operate devices like SimpleTest™, “crafting a market solution.” Rite Aid’s 3 Pilot stores in the Northeast USA have completely redone the pharmacy and have improved their included remote health solutions.
iAssay is squarely answering current and future market trends in the healthcare industry. Please see iAssay on www.WeFunder.com/iAssay